HEMISPHERX Trademark

Trademark Overview


On Friday, June 7, 2019, a trademark application was filed for HEMISPHERX with the United States Patent and Trademark Office. The USPTO has given the HEMISPHERX trademark a serial number of 88464320. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 2, 2023. This trademark is owned by HEMISPHERX BIOPHARMA, INC.. The HEMISPHERX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS

Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS
hemispherx

General Information


Serial Number88464320
Word MarkHEMISPHERX
Filing DateFriday, June 7, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 2, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2019

Trademark Statements


Goods and ServicesIntravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS
Goods and ServicesPharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 27, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 27, 2019
Primary Code042
First Use Anywhere DateMonday, June 5, 1995
First Use In Commerce DateMonday, June 5, 1995

Trademark Owner History


Party NameAIM IMMUNOTECH INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressOCALA, FL 34473

Party NameHEMISPHERX BIOPHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOrlando, FL 32801

Party NameHEMISPHERX BIOPHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOrlando, FL 32801

Trademark Events


Event DateEvent Description
Tuesday, January 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 2, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, June 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 2, 2022SOU EXTENSION 5 GRANTED
Thursday, May 26, 2022SOU EXTENSION 5 FILED
Thursday, June 2, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 26, 2022TEAS EXTENSION RECEIVED
Thursday, November 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 23, 2021SOU EXTENSION 4 GRANTED
Tuesday, November 23, 2021SOU EXTENSION 4 FILED
Tuesday, November 23, 2021TEAS EXTENSION RECEIVED
Friday, May 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 26, 2021SOU EXTENSION 3 GRANTED
Wednesday, May 26, 2021SOU EXTENSION 3 FILED
Wednesday, May 26, 2021TEAS EXTENSION RECEIVED
Friday, November 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 25, 2020SOU EXTENSION 2 GRANTED
Wednesday, November 25, 2020SOU EXTENSION 2 FILED
Wednesday, November 25, 2020TEAS EXTENSION RECEIVED
Thursday, May 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 26, 2020SOU EXTENSION 1 GRANTED
Tuesday, May 26, 2020SOU EXTENSION 1 FILED
Tuesday, May 26, 2020TEAS EXTENSION RECEIVED
Tuesday, November 26, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 9, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 1, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 1, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 28, 2019ASSIGNED TO EXAMINER
Thursday, June 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 11, 2019NEW APPLICATION ENTERED IN TRAM